Level Four Advisory Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Level Four Advisory Services’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,920	Closed	-$1.02M	–	844
2022 Q4	$1.02M	Buy	+8,920	New	+$741K	0.08%	245
2022 Q3	–	Sell	-11,242	Closed	-$897K	–	601
2022 Q2	$897K	Buy	11,242 +2,549	+29%	+$241K	0.08%	231
2022 Q1	$915K	Sell	8,693 -1,286	-13%	-$125K	0.07%	261
2021 Q4	$1.07M	Buy	9,979 +3,720	+59%	+$406K	0.08%	239
2021 Q3	$686K	Buy	6,259 +251	+4%	+$26.1K	0.07%	240
2021 Q2	$563K	Buy	6,008 +542	+10%	+$49.9K	0.04%	372
2021 Q1	$503K	Buy	5,466 +2,347	+75%	+$198K	0.04%	379
2020 Q4	$228K	Buy	+3,119	New	+$232K	0.02%	530

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Level Four Advisory Services's HZNP Position: Q1 2023 in Review

Level Four Advisory Services sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 8,920 shares — an estimated $1.02M sold.

Level Four Advisory Services first reported a position in HZNP in Q4 2020 and held it in 8 quarters. The position peaked at $1.07M in Q4 2021. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Level Four Advisory Services reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Level Four Advisory Services sold 8,920 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $1.02M.
Level Four Advisory Services first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 8 quarters.
Level Four Advisory Services's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.07M in Q4 2021.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Level Four Advisory Services's 13F filing for Q1 2023, filed 5 Jun 2023.